Just.: Just - Evotec Biologics Receives Grant to Enable an Antibody Product for The Prevention of Covid-19
JUST - EVOTEC BIOLOGICS RECEIVES GRANT FOR COVID-19 MONOCLONAL ANTIBODY OPTIMISATION AND CELL LINE DEVELOPMENT FROM THE COVID-19 THERAPEUTICS ACCELERATOR
Read full article »
Just is a biotechnology firm that develops monoclonal antibody products for the biotherapeutic sector.
Read more